Fact CheckerSign in

NCT07437573CompletedPhase 3

Oncometabolic Surgery

Comparison of the Long-limb vs. Conventional Roux-en-Y Reconstruction After Distal Gastrectomy in Gastric Cancer Patients With Type II Diabetes(Multicenter Prospective Randomized Controlled Study)

Source: ClinicalTrials.gov · Last updated 27 Feb 2026

Brief summary (registry, in English)

Recently, the concept of "Onco-metabolic surgery" has emerged, and it is a theory that if anastomosis bypassing the duodenum and upper jejunum is performed after gastrectomy in gastric cancer patients with type 2 diabetes, diabetes can be expected to improve. The authors would like to compare and analyze the effect of long bowel Luwai gastrointestinal anastomosis in gastric cancer patients with type 2 diabetes in a multicenter prospective manner with that of type 2 diabetes gastric cancer patients who underwent a conventional Luwai gastrointestinal anastomosis.

Status (registry)
Completed
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
94 (actual)
First submitted
27 Jan 2026
Start date
7 Jul 2020
Primary completion date
7 May 2024
Lead sponsor
Korea University Guro Hospital
NCT number
NCT07437573

What you commit to

  • Study type: Interventional · Phase 3
  • Participants enrolled: 94
  • From 7 Jul 2020 to the primary completion date, 7 May 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • If you received chemotherapy treatment before gastric cancer surgery

Other illness

  • If you have a history of cancer other than gastric cancer in the last five years
  • Preoperative advanced gastric cancer is diagnosed, or gastric total resection is performed in the upper part
  • If you have a history of malabsorption

Who the study is looking for

  • Clinical Stage I Gastric Cancer
  • a patient aged 20 to 80
  • Dx of Type 2 Diabetes
  • Preoperative BMI ≥ 23 kg/m2

Age in the registry: 20 years to 79 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Korea University Guro Hospital
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.